Simply Wall St AtriCure, Inc. ( NASDAQ:ATRC ) shareholders would be excited to see that the share price has had a great month, posting...\n more…
Ticker Report AtriCure, Inc. (NASDAQ:ATRC - Get Free Report) has received a consensus rating of "Buy" from the nine analysts that are currently covering the company, MarketBeat Ratings reports. Nine research...\n more…
Ticker Report StockNews.com upgraded shares of AtriCure (NASDAQ:ATRC - Free Report) from a sell rating to a hold rating in a research note issued to investors on Wednesday morning. Several other analysts also...\n more…
Business Wire AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management...\n more…